Involvement of Heat Shock Proteins in Candida albicans Biofilm Formation

Journal of Molecular Microbiology and Biotechnology

Volumn 23, Issue 6, 2013, Pages 396-400

  Becherelli, Marco ^a   Tao, Jianshi ^a   Ryder, Neil S ^a  

^a GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

Author keywords

Biofilm formation; Candida albicans; Heat shock proteins

Indexed keywords

ALVESPIMYCIN; GELDANAMYCIN; HEAT SHOCK PROTEIN; MESSENGER RNA; FUNGAL PROTEIN;

ARTICLE; BACTERIAL GROWTH; BIOFILM; CANDIDA ALBICANS; FUNGAL GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANTIBIOTIC SENSITIVITY; CONTROLLED STUDY; FUNGAL CELL; FUNGAL STRAIN;

BIOFILMS; CANDIDA ALBICANS; GENE EXPRESSION PROFILING; HEAT-SHOCK PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION;

CANDIDA; CANDIDA ALBICANS;

EID: 84887126397     PISSN: 14641801     EISSN: 16602412     Source Type: Journal    
DOI: 10.1159/000351619     Document Type: Article

References (17)

1. Baillie GS, Douglas LJ: Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob Agents Chemother 1998; 42: 1900-1905. (Pubitemid 28363067)
2. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA: Biofilm formation by the fungal pathogen Candida albicans : development, architecture, and drug resistance. J Bacteriol 2001; 183: 5385-5394. (Pubitemid 32802612)
3. Clinical and Laboratory Standards Institute: Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard-third edition. CLSI document M27-A3. Wayne, CLSI, 2008.
4. Cowen LE, Lindquist S: Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi. Science 2005; 309: 2185-2189. (Pubitemid 41396062)
5. Dabrowa N, Howard DH: Heat shock and heat stroke proteins observed during germination of the blastoconidia of Candida albicans. Infect Immun 1984; 44: 537-539. (Pubitemid 14139027)
6. Finkel JS, Mitchell AP: Genetic control of Candida albicans biofilm development. Nat Rev Microbiol 2011; 9: 109-118.
7. Finkel JS, Xu W, Huang D, Hill EM, Desai JV, Woolford CA, Nett JE, Taff H, Norice CT, Andes DR, Lanni F, Mitchell AP: Portrait of Candida albicans adherence regulators. PLoS Pathog 2012; 8:e1002525.
8. Hawser SP, Norris H, Jessup CJ, Ghannoum MA: Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl] -2htetrazolium hydroxide (XTT) colorimetric method with the Standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol 1998; 36: 1450-1452. (Pubitemid 28208050)
9. Kuhn DM, Ghannoum MA: Candida biofilms: antifungal resistance and emerging therapeutic options. Curr Opin Invest Drugs 2004; 5: 186-197.
10. Murillo LA, Newport G, Lan CY, Habelitz S, Dungan J, Agabian NM: Genome-wide transcription profiling of the early phase of biofilm formation by Candida albicans. Eukaryot Cell 2005; 4: 1562-1573. (Pubitemid 41339111)
11. Pierce CG, Uppuluri P, Tristan AR, Wormley FL Jr, Mowat E, Ramage G, Lopez-Ribot JL: A simple and reproducible 96-well-plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc 2008; 9: 1494-1500.
12. Ramage G, Saville SP, Thomas DP, Lopez-Ribot JL: Candida biofilms: an update. Eukaryot Cell 2005; 4: 633-638. (Pubitemid 40600417)
13. Robbins N, Uppuluri P, Nett J, Rajendran R, Ramage G, Lopez-Ribot JL, Andes D, Cowen LE: Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS Pathog 2011; 7:e1002257.
14. Seneviratne CJ, Wang Y, Jin L, Abiko Y, Samaranayake LP: Candida albicans biofilm formation is associated with increased anti-oxidative capacities. Proteomics 2008; 8: 2936-2947.
15. Shapiro R, Uppuluri P, Zaas AK, Collins C, Senn H, Perfect JR, Heitman J, Cowen LE: Hsp90 orchestrates temperature dependent Candida albicans morphogenesis via Ras1-PKA signalling. Current Biol 2009; 19: 1-9.
16. Smith V, Sausville EA, Camalier RF, Fiebig HH, Burger AM: Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models. Cancer Chemother Pharmacol 2005; 56: 126-137. (Pubitemid 40884268)
17. Swoboda RK, Bertram G, Budge S, Gooday GW, Gow NA, Brown AJ: Structure and regulation of the Hsp90 gene from the pathogenic fungus Candida albicans. Infect Immun 1995; 63: 4506-4514.